Canon Medical to showcase world's first Ultra-High Resolution CT system at ASTRO 2018

NewsGuard 100/100 Score

At this year's American Society of Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas, October 21-24, 2018 (Booth #3737), Canon Medical Systems USA, Inc. will showcase its recently FDA-cleared Aquilion PrecisionTM, the world's first Ultra-High Resolution CT system. The system can resolve anatomy as small as 150 microns and is designed to provide more than twice the CT resolution as standard systems. Containing an all-new detector as well as tube, gantry and reconstruction technologies, the system may make it possible to help expand visualization of disease thanks to new features that offer improved image detail.

The Aquilion Precision CT system features innovative dose efficiency with detector channels that are only 0.25 mm thick. This combined with substantial improvements in scintillator quantum efficiency, detector circuitry and other DAS components, result in a dose-efficient detector with ultra-high resolution capabilities. The system features resolution never before seen in CT imaging with one of the industry's smallest Focal Spot Tube at 0.4 mm x 0.5 mm and the industry's first routine 1024 x 1024 Reconstruction Matrix.

"The Aquilion Precision sets a new bar for CT imaging," said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Canon Medical Systems USA. "With the highest level of resolution available in the CT market, our customers have the ability to better visualize disease, which can potentially help clinicians in treatment planning."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough imaging method enhances precision in prostate cancer treatment